Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:2674-2677

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zolk, O.
Right arrow Articles by Böhm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zolk, O.
Right arrow Articles by Böhm, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Gene expression
Right arrow Physiological and pathological control of gene expression

(Circulation. 2000;101:2674.)
© 2000 American Heart Association, Inc.


Brief Rapid Communications

Decreased Expression of the Cardiac LIM Domain Protein MLP in Chronic Human Heart Failure

Oliver Zolk, MD; Pico Caroni, PhD; Michael Böhm, MD

From Klinik III für Innere Medizin, Universität zu Köln, Köln, Germany (O.Z., M.B.), and Friedrich Miescher Institute, Basel, Switzerland (P.C.).

Correspondence to Prof Dr Michael Böhm, Klinik III für Innere Medizin, Joseph-Stelzmann-Str 9, 50924 Köln, Germany. E-mail michael.boehm{at}medizin.uni-koeln.de

Background—The cardiac LIM domain protein MLP, a member of the cysteine-rich protein family, is an essential regulator of cardiac muscle development. Mice with a disruption of the MLP gene resemble the morphological and clinical picture of dilated cardiomyopathy and heart failure in humans. We investigated whether altered MLP expression is significant for the pathogenesis of human heart failure.

Methods and Results—Immunohistochemistry and in situ hybridization confirmed the expression of MLP protein and mRNA in human cardiomyocytes. Western blot analysis revealed that the MLP peptide was present in the contractile protein fraction but not in the cytosolic or membrane fraction and that the binding of MLP to myofibrils required functional zinc finger domains. MLP immunoreactivity was decreased {approx}50% (P<0.05) in the left ventricular myocardium of patients with chronic heart failure due to dilated or ischemic cardiomyopathy compared with non-failing donor hearts. MLP mRNA expression, as assessed by Northern blot experiments, was not significantly different between failing and non-failing control hearts, which suggests that decreased MLP synthesis or increased MLP protein turnover, rather than a decreased number of RNA transcripts, may play a role.

Conclusions—Because MLP may promote myofibril assembly, the down-regulation of this adapter protein might play an essential role in myofibril derangement or impaired myofibril rearrangement in the failing human myocardium.


Key Words: heart failure • cardiomyopathy • genes • RNA




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
W. A. Linke
Sense and stretchability: The role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction
Cardiovasc Res, March 1, 2008; 77(4): 637 - 648.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. W. Donker, J. G. Maessen, F. Verheyen, F. C. Ramaekers, R. L. H. M. G. Spatjens, H. Kuijpers, C. Ramakers, P. M. H. Schiffers, M. A. Vos, H. J. G. M. Crijns, et al.
Impact of acute and enduring volume overload on mechanotransduction and cytoskeletal integrity of canine left ventricular myocardium
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2324 - H2332.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Thai, L. Castellano, E. Juneman, H. Phan, R. Do, M. A. Gaballa, and S. Goldman
Pretreatment With Angiotensin Receptor Blockade Prevents Left Ventricular Dysfunction and Blunts Left Ventricular Remodeling Associated With Acute Myocardial Infarction
Circulation, October 31, 2006; 114(18): 1933 - 1939.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Hoshijima, R. Knoll, M. Pashmforoush, and K. R. Chien
Reversal of Calcium Cycling Defects in Advanced Heart Failure: Toward Molecular Therapy
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A15 - A23.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Hilfiker-Kleiner, U. Landmesser, and H. Drexler
Molecular Mechanisms in Heart Failure: Focus on Cardiac Hypertrophy, Inflammation, Angiogenesis, and Apoptosis
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A56 - A66.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Hoshijima
Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1313 - H1325.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. T. Durham, O. M. Brand, M. Arnold, J. G. Reynolds, L. Muthukumar, H. Weiler, J. A. Richardson, and F. J. Naya
Myospryn Is a Direct Transcriptional Target for MEF2A That Encodes a Striated Muscle, {alpha}-Actinin-interacting, Costamere-localized Protein
J. Biol. Chem., March 10, 2006; 281(10): 6841 - 6849.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Heineke, H. Ruetten, C. Willenbockel, S. C. Gross, M. Naguib, A. Schaefer, T. Kempf, D. Hilfiker-Kleiner, P. Caroni, T. Kraft, et al.
Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc
PNAS, February 1, 2005; 102(5): 1655 - 1660.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Zolk, M. Marx, E. Jackel, A. El-Armouche, and T. Eschenhagen
{beta}-Adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase
Cardiovasc Res, September 1, 2003; 59(3): 563 - 572.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
Y. Chen, S. Park, Y. Li, E. Missov, M. Hou, X. Han, J. L. Hall, L. W. Miller, and R. J. Bache
Alterations of gene expression in failing myocardium following left ventricular assist device support
Physiol Genomics, August 15, 2003; 14(3): 251 - 260.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Badorff and S. Dimmeler
NO Balance: Regulation of the Cytoskeleton in Congestive Heart Failure by Nitric Oxide
Circulation, March 18, 2003; 107(10): 1348 - 1349.
[Full Text] [PDF]


Home page
CirculationHome page
J. Heineke, T. Kempf, T. Kraft, A. Hilfiker, H. Morawietz, R. J. Scheubel, P. Caroni, S. M. Lohmann, H. Drexler, and K. C. Wollert
Downregulation of Cytoskeletal Muscle LIM Protein by Nitric Oxide: Impact on Cardiac Myocyte Hypertrophy
Circulation, March 18, 2003; 107(10): 1424 - 1432.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. Knoll, M. Hoshijima, and K.R. Chien
Z-line proteins: implications for additional functions
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I13 - I17.
[Abstract] [PDF]


Home page
Physiol. Rev.Home page
D. Fatkin and R. M. Graham
Molecular Mechanisms of Inherited Cardiomyopathies
Physiol Rev, October 1, 2002; 82(4): 945 - 980.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. C. Ferreira-Cornwell, Y. Luo, N. Narula, J. M. Lenox, M. Lieberman, and G. L. Radice
Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart
J. Cell Sci., April 15, 2002; 115(8): 1623 - 1634.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
E. Ehler, R. Horowits, C. Zuppinger, R. L. Price, E. Perriard, M. Leu, P. Caroni, M. Sussman, H. M. Eppenberger, and J.-C. Perriard
Alterations at the Intercalated Disk Associated with the Absence of Muscle LIM Protein
J. Cell Biol., May 14, 2001; 153(4): 763 - 772.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M.H. Yacoub
A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery
Eur. Heart J., April 1, 2001; 22(7): 534 - 540.
[PDF]


Home page
CirculationHome page
M. D. Schneider and R. J. Schwartz
Chips Ahoy : Gene Expression in Failing Hearts Surveyed by High-Density Microarrays
Circulation, December 19, 2000; 102(25): 3026 - 3027.
[Full Text] [PDF]


Home page
CirculationHome page
A. M. Katz
Cytoskeletal Abnormalities in the Failing Heart : Out on a LIM?
Circulation, June 13, 2000; 101(23): 2672 - 2673.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Ufret-Vincenty, D. J. Baro, W. J. Lederer, H. A. Rockman, L. E. Quinones, and L. F. Santana
Role of Sodium Channel Deglycosylation in the Genesis of Cardiac Arrhythmias in Heart Failure
J. Biol. Chem., July 20, 2001; 276(30): 28197 - 28203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. H. Omens, T. P. Usyk, Z. Li, and A. D. McCulloch
Muscle LIM protein deficiency leads to alterations in passive ventricular mechanics
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H680 - H687.
[Abstract] [Full Text] [PDF]